Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain

Journal of Clinical Psychopharmacology

Volumn 33, Issue 3, 2013, Pages 436-437

  Godlewska, Beata R ^a   Olajossy Hilkesberger, Luiza ^b   Olajossy, Marcin ^b   Limon, Janusz ^a   Landowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HISTAMINE H1 RECEPTOR; OLANZAPINE; SEROTONIN 2C RECEPTOR;

ADULT; ALLELE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG DOSE TITRATION; FEMALE; FOOD INTAKE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MONOTHERAPY; OBESITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT GAIN;

ADULT; ALLELES; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, HISTAMINE H1; SCHIZOPHRENIA; WEIGHT GAIN; YOUNG ADULT;

EID: 84877579115     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182900c9e     Document Type: Letter

References (13)

1. Godlewska BR, Olajossy-Hilkesberger L, Ciwoniuk M, et al. Olanzapine-induced weight gain is associated with the-759C/T and-697G/C polymorphisms of the HTR2C gene. Pharmacogenomics J. 2009; 9: 234-241.
2. Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003; 28: 519-526.
3. Matsui-Sakata A, Ohtani H, Sawada Y. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus. Drug Metab Pharmacokinet. 2005; 20: 368-378.
4. Masaki T, Chiba S, Yasuda T, et al. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes. 2004; 53: 2250-2260.
5. Sakata T, Yoshimatsu H, Kurokawa M. Hypothalamic neuronal histamine: implications of its homeostatic control of energymetabolism. Nutrition. 1997; 13: 403-411.
6. Han M, Deng C, Burne TH, et al. Short-and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Psychoneuroendocrinology. 2008; 33: 569-580.
7. Deng C, Weston-Green K, Huang XF. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34: 1-4.
8. George SA, Khan S, Briggs H, et al. CRH-stimulated cortisol release and food intake in healthy, non-obese adults. Psychoneuroendocrinology. 2010; 35: 607-612.
9. Mancama D, Arranz MJ, Munro J, et al. The histamine 1 and histamine 2 receptor genesVcandidates for schizophrenia and clozapine drug response. GeneScreen. 2000; 1: 29-34.
10. Mancama D, Arranz MJ, Munro J, et al. Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci Lett. 2002; 333: 207-211.
11. Basile VS, Masellis M, McIntyre RS, et al. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry. 2001; 62(suppl 23): 45-66.
12. Hong CJ, Lin CH, Yu YW, et al. Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment. Psychiatr Genet. 2002; 12: 169-171.
13. Ujike H, Nomura A, Morita Y, et al. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry. 2008; 69: 1416-1422.